FGF21 showed the highest sensitivity of all (68%; 95% CI: 43.5–87.4; Fig 6A), when including all MD patients, and when considering only muscle‐manifesting MDs—known to induce FGF21 secretion—its sensitivity in this material was 91% (95% CI: 66.4–100.0; Fig EV1B). The gene discussed is FGF21; the disease is myelodysplastic syndrome.